Edmond De Rothschild Holding S.A. Biogen Inc. Transaction History
Edmond De Rothschild Holding S.A.
- $5.7 Billion
- Q4 2024
A detailed history of Edmond De Rothschild Holding S.A. transactions in Biogen Inc. stock. As of the latest transaction made, Edmond De Rothschild Holding S.A. holds 60,070 shares of BIIB stock, worth $8.85 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
60,070
Previous 60,070
-0.0%
Holding current value
$8.85 Million
Previous $11.6 Million
21.11%
% of portfolio
0.16%
Previous 0.19%
Shares
26 transactions
Others Institutions Holding BIIB
# of Institutions
1,002Shares Held
131MCall Options Held
1.77MPut Options Held
2.34M-
Vanguard Group Inc Valley Forge, PA16.7MShares$2.47 Billion0.05% of portfolio
-
Primecap Management CO Pasadena, CA16MShares$2.36 Billion1.94% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.14 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.4MShares$1.09 Billion0.05% of portfolio
-
Wellington Management Group LLP Boston, MA4.93MShares$727 Million0.14% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $21.2B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...